Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

November 11, 2024
HealthDayTV HealthDay Reporter

New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.

Heart / Stroke-Related: Heart Attack Diabetes: Misc.Obesity Heart / Stroke-Related: Stroke Weight Loss

Health News is provided as a service to Main Discount Drug Center site users by HealthDay. Main Discount Drug Center nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

(330) 876-1228

Patient Resources

Get Healthy!

Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags